Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

Cited In for PubMed (Select 10796393)

1.

Comparison of two different folic acid doses with methotrexate--a randomized controlled trial (FOLVARI Study).

Dhir V, Sandhu A, Kaur J, Pinto B, Kumar P, Kaur P, Gupta N, Sood A, Sharma A, Sharma S.

Arthritis Res Ther. 2015 Jun 11;17:156. doi: 10.1186/s13075-015-0668-4.

2.

Specific management of post-chikungunya rheumatic disorders: a retrospective study of 159 cases in Reunion Island from 2006-2012.

Javelle E, Ribera A, Degasne I, Gaüzère BA, Marimoutou C, Simon F.

PLoS Negl Trop Dis. 2015 Mar 11;9(3):e0003603. doi: 10.1371/journal.pntd.0003603. eCollection 2015 Mar.

3.

The possibilities and principles of methotrexate treatment of psoriasis - the updated knowledge.

Czarnecka-Operacz M, Sadowska-Przytocka A.

Postepy Dermatol Alergol. 2014 Dec;31(6):392-400. doi: 10.5114/pdia.2014.47121. Epub 2014 Dec 3. Review.

4.

Role of key TYMS polymorphisms on methotrexate therapeutic outcome in portuguese rheumatoid arthritis patients.

Lima A, Seabra V, Bernardes M, Azevedo R, Sousa H, Medeiros R.

PLoS One. 2014 Oct 3;9(10):e108165. doi: 10.1371/journal.pone.0108165. eCollection 2014.

5.

Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms.

Lima A, Monteiro J, Bernardes M, Sousa H, Azevedo R, Seabra V, Medeiros R.

Biomed Res Int. 2014;2014:368681. doi: 10.1155/2014/368681. Epub 2014 May 21.

6.

Involvement of Multiple Transporters-mediated Transports in Mizoribine and Methotrexate Pharmacokinetics.

Murakami T, Mori N.

Pharmaceuticals (Basel). 2012 Aug 10;5(8):802-36. doi: 10.3390/ph5080802.

7.

Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease.

Micha R, Imamura F, Wyler von Ballmoos M, Solomon DH, Hernán MA, Ridker PM, Mozaffarian D.

Am J Cardiol. 2011 Nov 1;108(9):1362-70. doi: 10.1016/j.amjcard.2011.06.054. Epub 2011 Aug 17. Review.

8.

Going with the flow: methotrexate, adenosine, and blood flow.

Cronstein BN.

Ann Rheum Dis. 2006 Apr;65(4):421-2. No abstract available.

9.
10.

ASAS/EULAR recommendations for the management of ankylosing spondylitis.

Zochling J, van der Heijde D, Burgos-Vargas R, Collantes E, Davis JC Jr, Dijkmans B, Dougados M, Géher P, Inman RD, Khan MA, Kvien TK, Leirisalo-Repo M, Olivieri I, Pavelka K, Sieper J, Stucki G, Sturrock RD, van der Linden S, Wendling D, Böhm H, van Royen BJ, Braun J; 'ASsessment in AS' international working group; European League Against Rheumatism.

Ann Rheum Dis. 2006 Apr;65(4):442-52. Epub 2005 Aug 26.

11.

Molecular action of methotrexate in inflammatory diseases.

Chan ES, Cronstein BN.

Arthritis Res. 2002;4(4):266-73. Epub 2002 Mar 19. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk